2012-5208. Advisory Committees; Filing of Closed Meeting Reports

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing that, as required by the Federal Advisory Committee Act, the Agency has filed with the Library of Congress the annual reports of those FDA advisory committees that held closed meetings during fiscal year 2011.

ADDRESSES:

Copies are available from the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 301-827-6860.

FOR FURTHER INFORMATION CONTACT:

Teresa L. Hays, Advisory Committee and Oversight Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-8220.

SUPPLEMENTARY INFORMATION:

Under section 10(d) of the Federal Advisory Committee Act (5 U.S.C. app.) and 21 CFR 14.60(d), FDA has filed with the Library of Congress the annual reports for the following FDA advisory committees that held closed meetings during the period October 1, 2010 through September 30, 2011:

Center for Biologics Evaluation and Research

Allergenic Products Advisory Committee

Blood Products Advisory Committee

Cellular, Tissue and Gene Therapies Advisory Committee

Vaccines and Related Biological Products Advisory Committee

Center for Drug Evaluation and Research

Cardiovascular and Renal Drugs Advisory Committee

Gastrointestinal Drug Advisory Committee

National Center for Toxicological Research

Science Board to the National Center for Toxicological Research

Center for Tobacco Products

Tobacco Products Scientific Advisory Committee

Annual reports are available for public inspections between 9 a.m. and 4 p.m., Monday through Friday.

• The Library of Congress, Madison Bldg., Newspaper and Current Periodical Reading Room, 101 Independence Ave. SE., Rm. 133, Washington, DC; and
• The Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Dated: February 23, 2012.

Jill Hartzler Warner,

Acting Associate Commissioner for Special Medical Programs.